JG
MDCO

Jefferies Group’s Medicines Co MDCO Stock Holding History

Jefferies Group’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-122,100
Closed -$10.4M – 2948
2019
Q4 		$10.4M Buy
122,100
+57,900
+90% +$3.86M 0.08% 220
2019
Q3 		$3.21M Buy
+64,200
New +$2.56M 0.02% 766
2018
Q4 		– Sell
-18,200
Closed -$544K – 2795
2018
Q3 		$544K Sell
18,200
-34,700
-66% -$1.31M ﹤0.01% 1599
2018
Q2 		$1.94M Buy
+52,900
New +$1.72M 0.01% 906
2016
Q1 		– Sell
-39,300
Closed -$1.47M – 2716
2015
Q4 		$1.47M Buy
+39,300
New +$1.49M 0.01% 1003
2015
Q3 		– Sell
-8,200
Closed -$235K – 3375
2015
Q2 		$235K Sell
8,200
-96,100
-92% -$2.68M ﹤0.01% 1893
2015
Q1 		$2.92M Buy
+104,300
New +$2.93M 0.02% 614

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Jefferies Group's MDCO Position: Q1 2020 in Review

Jefferies Group sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 158,197 shares — an estimated $13.4M sold.

Jefferies Group first reported a position in MDCO in Q4 2013 and held it in 14 quarters. The position peaked at $13.4M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Jefferies Group reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Jefferies Group sold 158,197 Medicines Co shares in Q1 2020, an estimated $13.4M.
  • Jefferies Group first reported a position in Medicines Co in Q4 2013 and held it in 14 quarters.
  • Jefferies Group's Medicines Co position peaked at $13.4M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Jefferies Group's 13F filing for Q1 2020, filed 15 May 2020.